Toggle navigation
Home
Search
Services
Blog
Contact
About
Open Tolerability Study of Add 106024 in Patients
Schomer, Donald
Children's Hospital Boston, Boston, MA, United States
Search 4 grants from Donald Schomer
Search grants from Children's Hospital Boston
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The SMAD3 signaling network in coronary artery disease risk
Cell Surface Plasminogen Activation and Hypertension
Effect of Bacterial Tolerance on TLR4 Signal Transduction
Neuropathology Core
Molecular Genetics of Integrin Collagen Receptors
Recently added grants:
Program 11: Cancer Immunology
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
Maternal buprenorphine-naloxone treatment during the perinatal period: Fetal and infant effects
Program 12: Developmental Therapeutics
Program 13: Cancer Risk and Disparities
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research and Development Contracts (N01)
Project #
N01NS012380-001001
Application #
3668919
Study Section
Project Start
1985-09-30
Project End
Budget Start
1986-07-01
Budget End
1987-03-29
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1987
N01 NS
Open Tolerability Study of Add 106024 in Patients
Schomer, Donald / Children's Hospital Boston
NIH 1986
N01 NS
Open Tolerability Study of Add 106024 in Patients
Schomer, Donald / Children's Hospital Boston
NIH 1985
N01 NS
Open Tolerability Study of Add 106024 in Patients
Lombroso, Cesare T. / Children's Hospital Boston
Publications
Mikati, M A; Schachter, S C; Schomer, D L et al.
(1989)
Long-term tolerability, pharmacokinetic and preliminary efficacy study of lamotrigine in patients with resistant partial seizures.
Clin Neuropharmacol 12:312-21
Comments
Be the first to comment on Donald Schomer's grant